OCA2 and malaria: Although, our data need to be confirmed and supported by in vivo data from mefloquine-treated patients or in vitro experiments showing a direct relationship between mefloquine pressure and P. vivaxmdr-1 amplification, our findings advocate for an integrated drug policy whereby all sympatric malaria species are considered regarding treatment efficacy but also drug pressure and selection of resistance.